KMPH
|
$5.46
6.04%
0
|
Manufacturing
(0.0% 1d)
(0.7% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.7% 7d)
(NaN%
volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 188,396,547
http://www.kempharm.com/
Sec
Filling
|
Patents
| 22 employees
(US) KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT™ technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.
urea
treatment
profitable
add to watch list
Paper trade
email alert is off
LNFA
4
|
$10.57
3.6%
|
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(15411.4%
volume)
Earnings Calendar:
Market Cap: $ 36,209,533
https://lfacquisitioncorp.com
Sec
Filling
|
Patents
| n/a employees
L&F Acquisition Corp. is a blank check company formed for the purpose of entering into a combination with one or more businesses, with the intent to concentrate on identifying technology and services businesses in the Governance, Risk, Compliance and Legal (“GRCL”) sector. L&F Acquisition Corp. is sponsored by JAR Sponsor, LLC, a newly organized special purpose vehicle.
acquisitions
blank check
vehicles
ycombinator
add to watch list
Paper trade
email alert is off
OMEG
|
$10.1
0.2%
0.2%
|
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(615.74%
volume)
Earnings Calendar:
Market Cap: $ 144,440,100
Sec
Filling
|
Patents
| n/a employees
Omega Alpha SPAC, sponsored by an affiliate of Omega Fund VI, L.P., is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. Omega Alpha SPAC expects that its focus will be on the biotechnology sector in developed countries including, but not limited to, the United States and countries in Europe.
msa
acquisitions
spac
blank check
add to watch list
Paper trade
email alert is off
PHIC
|
$10.07
-0.1%
0.0%
|
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(-98.7%
volume)
Earnings Calendar:
Market Cap:
Sec
Filling
|
Patents
| 5 employees
Population Health Investment Co., Inc. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus on companies or divisions of companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries.
acquisitions
blank check
add to watch list
Paper trade
email alert is off
PIPP
|
$10.03
0.0%
|
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(280.79%
volume)
Earnings Calendar:
Market Cap: $ 219,043,164
Sec
Filling
|
Patents
| 100 employees
add to watch list
Paper trade
email alert is off
CGEM
|
$16.645
6.49%
6.07%
970K
|
(0.0% 1d)
(-7.7% 1m)
(46.3% 1y)
(0.0% 2d)
(0.0% 3d)
(-0.2% 7d)
(-0.18%
volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 716,827,661
https://www.cullinanoncology.com
Sec
Filling
|
Patents
| 24 employees
(US) Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.
cancer
ycombinator
add to watch list
Paper trade
email alert is off
CLOV
|
News
F
|
$0.634
1.9%
1.86%
3.5M
|
(0.0% 1d)
(-21.6% 1m)
(-19.5% 1y)
(0.0% 2d)
(0.0% 3d)
(-3.1% 7d)
(-10.61%
volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 257,177,723
https://www.cloverhealth.com
Sec
Filling
|
Patents
| 458 employees
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As a company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with physicians to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover has offices in San Francisco, Jersey City, Nashville and Hong Kong.
msa
education
add to watch list
Paper trade
email alert is off
LSEA
|
$11.4
2.06%
2.02%
110K
|
(0.0% 1d)
(-20.3% 1m)
(79.9% 1y)
(0.0% 2d)
(0.0% 3d)
(0.1% 7d)
(-31.22%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 410,647,825
https://landseahomes.com
Sec
Filling
|
Patents
| 253 employees
Landsea Homes Corporation is a publicly traded residential homebuilder based in Newport Beach, CA that designs and builds best-in-class homes and sustainable master-planned communities in some of the nation's most desirable markets. The company has developed homes and communities in New York, Boston, New Jersey, Arizona, and throughout California in Silicon Valley, Los Angeles and Orange County.
add to watch list
Paper trade
email alert is off
MODV
4
|
$22.53
2.41%
2.35%
270K
|
Health Care and Social Assistan...
(0.0% 1d)
(-6.7% 1m)
(-69.7% 1y)
(0.0% 2d)
(0.0% 3d)
(6.0% 7d)
(33.44%
volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 319,884,117
https://www.prscholdings.com/
Sec
Filling
|
Patents
| 7100 employees
(US) Providence Service Corporation is an Atlanta, Georgia-based American social services corporation listed on the NASDAQ. Providence Service Corporation was established in 1997. It has a payroll of approximately 7,100. Its Chairman is Christopher S. Shackelton and its current Chief Executive Officer is Daniel E. Greenleaf.
add to watch list
Paper trade
email alert is off